Skip to content

Chemours CC Income Loss From Equity Method Investments Net Of Dividends Or Distributions

Income Loss From Equity Method Investments Net Of Dividends Or Distributions at other companies

DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
Dow logo
DowDOW
Celanese Corporation logo
Celanese CorporationCE
Worthington Enterprises logo
Worthington EnterprisesWOR

Other financials

Income statement

See full
Revenue$1.4B+1.0%
Gross profit$212.0M-10.2%
Net income-$29.0M-480%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$563.0M+21.3%
Total debt$4.4B0.0%
Total equity$215.0M-62.0%
Total assets$7.3B-1.5%

Cash flow

See full
Operating cash flow-$44.0M+60.7%
CapEx$49.0M-41.7%
Free cash flow-$93.0M+52.6%

Valuation

See full
Market cap$3B+63.6%

Profitability

See full
Gross margin15.1%-3.8pp
Net margin-7%-7.3pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemours's income loss from equity method investments net of dividends or distributions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemours's income loss from equity method investments net of dividends or distributions?
Chemours (CC) reported income loss from equity method investments net of dividends or distributions of $6M in Q1 2026.
How has Chemours's income loss from equity method investments net of dividends or distributions changed year-over-year?
Chemours's income loss from equity method investments net of dividends or distributions decreased by 14.3% year-over-year, from $7M to $6M.